Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$1.12
-5.46%
Mkt Cap $47.65M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
Implied Upside
+2192.0%
Consensus $25.67 vs current $1.12
NYSE·Healthcare·Biotechnology
$1.12
-5.46%
Mkt Cap $47.65M
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
+2192.0%
Consensus $25.67 vs current $1.12